Reports

Three drug manufacturers control the global insulin market and have raised prices on American patients by nearly 300% in the last ten years.

This system enables pharmaceutical companies to turn taxpayer investment into unrestrained profit without regard to affordability or accessibility.

P4AD Analysis of 2017 Medicare Part D Spending

How one of the world’s top-5 pharmaceutical corporations rips off America.

How Pfizer's price hikes pad profits and hurt patients.